Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

NCT00036556 ·Status: COMPLETED ·Phase: PHASE3

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

NCT05458856 ·Status: COMPLETED ·Phase: PHASE3

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate

NCT01858441 ·Status: COMPLETED ·Phase: NA

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

NCT03611686 ·Status: ACTIVE_NOT_RECRUITING

Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

NCT03927391 ·Status: COMPLETED ·Phase: PHASE4

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

NCT03655886 ·Status: COMPLETED ·Phase: PHASE2

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

NCT02238366 ·Status: COMPLETED

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

NCT00124566 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

NCT02230059 ·Status: COMPLETED

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

NCT01620593 ·Status: COMPLETED ·Phase: PHASE2

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

NCT01076751 ·Status: TERMINATED

Recommended Dose Estimation of BP-C2

NCT04186585 ·Status: RECRUITING ·Phase: PHASE1

Open Label Trial to Assess Iressa in Prostate Cancer Patients

NCT00635856 ·Status: COMPLETED ·Phase: PHASE2

A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care

NCT02236637 ·Status: COMPLETED

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

NCT02008058 ·Status: COMPLETED

Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

NCT01429064 ·Status: COMPLETED ·Phase: PHASE2

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

NCT01254279 ·Status: COMPLETED ·Phase: PHASE3

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

NCT05303558 ·Status: COMPLETED

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

NCT00564928 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

NCT04593420 ·Status: COMPLETED

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

NCT01505868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

NCT00014586 ·Status: TERMINATED ·Phase: PHASE3